ICON Public Limited Company

NasdaqGS:ICLR Stock Report

Market Cap: US$16.9b

ICON Future Growth

Future criteria checks 1/6

ICON is forecast to grow earnings and revenue by 12.9% and 4.7% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 11.7% in 3 years.

Key information

12.9%

Earnings growth rate

14.2%

EPS growth rate

Life Sciences earnings growth17.9%
Revenue growth rate4.7%
Future return on equity11.7%
Analyst coverage

Good

Last updated18 Dec 2024

Recent future growth updates

ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 28
ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

ICON: A High Probability Of Success In The Uncertain R&D Process

Dec 13

At US$219, Is ICON Public Limited Company (NASDAQ:ICLR) Worth Looking At Closely?

Dec 10
At US$219, Is ICON Public Limited Company (NASDAQ:ICLR) Worth Looking At Closely?

ICON: Disappointing Change In Trajectory (Rating Downgrade)

Nov 29

With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For

Nov 02
With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For

Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors

Sep 25
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors

Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Sep 09
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

Aug 25
We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued

Aug 10
An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued

ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

Jul 13

Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Jun 14
Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

May 30
Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

May 14
ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 28
ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

Apr 21
What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

Apr 05
ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

Mar 05
ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Feb 07
With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?

Feb 01

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Jan 23
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Jan 08
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

Dec 24
What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

Icon selected by BARDA to conduct anthrax vaccine clinical trial

Oct 06

Earnings and Revenue Growth Forecasts

NasdaqGS:ICLR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269,0441,0381,3621,49313
12/31/20258,5199121,2931,32916
12/31/20248,2757301,1261,23216
9/30/20248,3077481,2291,388N/A
6/30/20248,3327141,1821,327N/A
3/31/20248,2326831,1721,313N/A
12/31/20238,1206121,0201,161N/A
9/30/20238,016513516661N/A
6/30/20237,903510381534N/A
3/31/20237,818510363512N/A
12/31/20227,741505421563N/A
9/30/20227,665464780913N/A
6/30/20227,588210878998N/A
3/31/20226,524168839944N/A
12/31/20215,481153735829N/A
9/30/20214,356178676735N/A
6/30/20213,191364506548N/A
3/31/20212,940338499537N/A
12/31/20202,797328527568N/A
9/30/20202,762322460507N/A
6/30/20202,771324502556N/A
3/31/20202,846368406461N/A
12/31/20192,806369374413N/A
9/30/20192,759362287339N/A
6/30/20192,704353257306N/A
3/31/20192,651333276323N/A
12/31/20182,596323220269N/A
9/30/20182,372306264314N/A
6/30/20182,157295N/A294N/A
3/31/20181,947288N/A264N/A
12/31/20171,758281N/A383N/A
9/30/20171,738285N/A407N/A
6/30/20171,718274N/A350N/A
3/31/20171,698271N/A359N/A
12/31/20161,666262N/A259N/A
9/30/20161,635251N/A245N/A
6/30/20161,609249N/A267N/A
3/31/20161,587247N/A277N/A
12/31/20151,575240N/A279N/A
9/30/20151,562221N/A239N/A
6/30/20151,555210N/A275N/A
3/31/20151,542192N/A192N/A
12/31/20141,503172N/A169N/A
9/30/20141,458161N/A192N/A
6/30/20141,411138N/A125N/A
3/31/20141,369120N/A191N/A
12/31/20131,336103N/A221N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ICLR's forecast earnings growth (12.9% per year) is above the savings rate (2.6%).

Earnings vs Market: ICLR's earnings (12.9% per year) are forecast to grow slower than the US market (15.3% per year).

High Growth Earnings: ICLR's earnings are forecast to grow, but not significantly.

Revenue vs Market: ICLR's revenue (4.7% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: ICLR's revenue (4.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ICLR's Return on Equity is forecast to be low in 3 years time (11.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 07:16
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ICON Public Limited Company is covered by 45 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Armelle MoulinAlphaValue
Gregory BolanAvondale Partners
Eric ColdwellBaird